E. Gerald Kay - May 6, 2022 Form 4/A - Amendment Insider Report for INTEGRATED BIOPHARMA INC (INBP)

Role: Executive Chairman & President, Director, 10%+ Owner
Signature: /s/ E. Gerald Kay
Stock symbol: INBP
Transactions as of: May 6, 2022
Transactions value $: $23,000
Form type: 4/A - Amendment
Date filed: 5/11/2022, 02:37 PM
Date Of Original Report: May 6, 2022
Previous filing: Nov 4, 2021
Next filing: Nov 10, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	INBP	Common Stock	Options Exercise	$23K	+100K	+1.91%	$0.23	5.35M	May 6, 2022	Direct	F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	INBP	Stock Option (right to buy)	Options Exercise	$0	-100K	-40%	$0.00	150K	May 6, 2022	Common Stock	100K	$0.23	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This Form 4 is being amended to correct the Transaction Code in Table 1 and to include the previously inadvertently omitted disclosure in Table II.
F2	100,000 common stock shares acquired upon exercise of stock option grant dated May 24, 2019.
F3	The option vested 50% (125,000) on grant date (May 24, 2019) and in three equal annual installments for the remaining 50% (125,000) beginning on May 24, 2020 and ending May 24, 2022.